Nutex Health (NASDAQ:NUTX) Shares Up 12.7% – Should You Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s share price rose 12.7% during trading on Friday . The company traded as high as $171.42 and last traded at $171.30. Approximately 83,451 shares changed hands during trading, a decline of 51% from the average session volume of 170,086 shares. The stock had previously closed at $151.93.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 target price for the company. Lake Street Capital started coverage on Nutex Health in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target on the stock. Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Zacks Research raised shares of Nutex Health to a “hold” rating in a research report on Monday, June 29th. Finally, Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $243.33.

Nutex Health Price Performance

The firm has a market capitalization of $1.17 billion, a P/E ratio of 13.02 and a beta of 0.24. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $156.57 and its 200-day moving average is $128.97.

Hedge Funds Weigh In On Nutex Health

Several hedge funds and other institutional investors have recently modified their holdings of the business. Hussman Strategic Advisors Inc. acquired a new stake in Nutex Health in the fourth quarter valued at approximately $3,457,000. Empowered Funds LLC bought a new stake in shares of Nutex Health during the first quarter worth $3,084,000. SG Americas Securities LLC increased its holdings in shares of Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after buying an additional 29,449 shares in the last quarter. Smith Group Asset Management LLC acquired a new position in shares of Nutex Health during the first quarter worth $1,244,000. Finally, JPMorgan Chase & Co. lifted its stake in shares of Nutex Health by 78.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 14,782 shares of the company’s stock valued at $1,527,000 after acquiring an additional 6,476 shares during the last quarter. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.